Article
Tumor interstitial fluid promotes malignant phenotypes of lung cancer independently of angiogenesis.
Cancer prevention research (Philadelphia, Pa.) - 1 Nov 2015
Li Hong, Li Ganggang, Liu Linxin, Guo Zhenzhen, Ma Xiaofang, Cao Ning, Lin Haihong, Han Guang, Duan Yongjian, Du Gangjun
Abstract excerpt
Angiogenesis is necessary for cancer progression, but antiangiogenic therapy actually promotes tumor recurrence, progression, and metastasis. This study focused on the contribution of the tumor interstitial fluid (TIF) to lung cancer progression. TIF was isolated and quantified for 10 μg protein/mL. Malignant driver characteristics of TIF were examined by tumor-initiating cells (TIC), self-renewal,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
